Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://lilianjfyl995738.blogoscience.com/47249562/tirzepatide-a-new-frontier-in-diabetes-treatment